Cedric Francois - Chief Executive Officer, Apellis Pharmaceuticals, Inc

As of February 14, 2022


What is Cedric Francois's Net Worth?

The current estimated net worth of Apellis Pharmaceuticals, Inc's Chief Executive Officer, Cedric Francois, is estimated to be about $50.91M . Cedric Francois owns about 1,347,490 units of Apellis Pharmaceuticals, Inc common stock. In the last 4 years at Apellis Pharmaceuticals, Inc, Cedric Francois has sold an estimated value of $6.38M worth.

What is Cedric Francois's Past Insider Trading?

Cedric Francois's largest purchase order was 61,274 units , worth over $131.13K on March 18, 2020. Cedric Francois's largest sale order was 35,638 units , worth over $1.5M on January 17, 2020. In total, Cedric Francois has made about 33 transactions over 4 years of their time at Apellis Pharmaceuticals, Inc. Cedric Francois usually trades in February, with the busiest year in 2020. The most recent transaction was a sale order of 5,000 units , worth over $260.8K on December 16, 2020.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Cedric Francois's Salary in 2020?

As Chief Executive Officer of Apellis Pharmaceuticals, Inc, Cedric Francois has a total base salary of $618,769 . Cedric Francois received compensation valued at about $9,275,425 in 2020 after becoming Chief Executive Officer. The vast majority of their compensation came in the form of a bonus of $429,687 , stock awards of $1,523,844 , option awards of $6,703,125 , and

What is Cedric Francois's' Mailing Address?

  • Mailing address is 6400 Westwind Way Suite A Crestwood KY 40014 KY

Apellis Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Cedric Francois, M.D., Ph.D. 2020 $618,769 $429,687 $1,523,844 $6,703,125 - $9,275,425
Cedric Francois, M.D., Ph.D. 2019 $560,019 $427,893 - $3,279,270 - $4,267,182
Cedric Francois, M.D., Ph.D. 2018 $550,000 $381,562 - $3,127,600 $15,378 $4,074,540
Timothy Sullivan 2020 $430,269 $244,688 $518,129 $2,279,063 $13,000 $3,485,149
Timothy Sullivan 2019 $386,423 $214,730 - $1,108,650 $9,500 $1,719,303
Timothy Sullivan 2018 $380,000 $190,000 - $279,250 $10,502 $859,752
Pascal Deschatelets, Ph.D. 2020 $423,500 $239,062 $415,594 $1,828,125 $11,801 $2,918,082
Pascal Deschatelets, Ph.D. 2019 $404,077 $252,608 - $1,108,650 $55,893 $1,821,228
Pascal Deschatelets, Ph.D. 2018 $400,000 $225,000 - $1,228,700 $8,657 $1,862,357
Nur Nicholson 2020 $138,462 $150,068 - $2,648,750 $84,874 $3,022,154
Adam Townsend 2020 $430,038 $217,500 $415,594 $1,828,125 $9,750 $2,901,007
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1492422/000119312521126688/d887358ddef14a.htm

What are Apellis Pharmaceuticals, Inc's Past Insider Trades?

Apellis Pharmaceuticals, Inc's most recent insider trade came on June 24, 2022 by A. Sinclair Dunlop who sold 15,000 units worth $675K . In the last 5 years, insiders at Apellis Pharmaceuticals, Inc have sold an estimated value of $44.04M and bought an estimated value of $94.04M worth of shares. Insider trading is most common in February, with the busiest year in 2021. The most active traders at the company are Federico Grossi, CHIEF MEDICAL OFFICER,  Cedric Francois, Chief Executive Officer,  and Alec MacHiels, Director .

Apellis Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1